Market Overview

Neurocrine Biosciences, Inc. (NASDAQ: NBIX)

89.48 +0.88 (0.99%)

Analyst Ratings

DateResearch FirmActionCurrentPT
12/13/18Goldman SachsInitiates Coverage OnBuy103.0
11/21/18Canaccord GenuityInitiates Coverage OnBuy111.0
11/13/18Leerink SwannInitiates Coverage OnMarket Perform110.0
11/06/18Morgan StanleyMaintainsOverweight135.0
9/20/18Stifel NicolausMaintainsBuy142.0
9/10/18Morgan StanleyInitiates Coverage OnOverweight145.0
8/23/18Cantor FitzgeraldInitiates Coverage OnOverweight150.0
8/07/18Stifel NicolausInitiates Coverage OnBuy137.0
8/01/18BarclaysMaintainsOverweight135.0
7/25/18BairdMaintainsOutperform122.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter